Access cutting-edge brain metastases treatment through this clinical trial at a research site in Ann Arbor. Study-provided care at no cost to qualified participants.
Access brain metastases specialists in Ann Arbor at no cost
This study follows strict safety protocols and ethical guidelines
All study-related brain metastases treatment provided free
This is an open-label, single dose, single arm, multicenter Phase 2b study to establish the imaging performance of RAD101 PET in participants who are ≥ 18 years of age and with suspected recurrent brain metastases from solid tumors. The study consists of a 4-week Screening Period, a 3-day Imaging and Safety Follow-Up Period, and a Data Collection Period of up to 6 months. Participant eligibility will be determined during the Screening Period and eligible participants will be enrolled in the stu
Sponsor: Radiopharm Theranostics, Ltd
Check if you qualify for this brain metastases clinical trial in Ann Arbor, MI
If you're searching for brain metastases treatment options in Ann Arbor, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Ann Arbor research site is actively enrolling participants for this clinical trial. You'll receive care from experienced brain metastases specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.